Total views : 215

An Epidemiological and Pharmacotherapy Study on Diabetic Foot Infections

Affiliations

  • Department of Pharmacy Practice, Visveswarapura Institute of Pharmaceutical Sciences, Bengaluru 560070, India
  • Department of Surgery, KIMS Hospital and Research Centre, Bengaluru 560004, India

Abstract


Objectives: To assess the epidemiology, risk factors and pharmacotherapy pattern and to provide patient education regarding care to be taken in diabetic foot infections.

Methods: A prospective observational study was carried out on 122 diabetic foot infection patients after obtaining the consent, from the surgery department of a tertiary care hospital. Socio-demographic data, laboratory data and pharmacotherapy data were documented in a self-structured data collection form and analyzed.

Findings: It was observed that male patients between the age group of 61-70 years and patients with long standing diabetes along with peripheral neuropathy were mostly affected. Risk factors included uncontrolled hyperglycemia and walking barefoot. Cephalosporin class of drugs followed by fluroquinolones and penicillins were the chief drug classes used in therapy. Patient education was provided using designed patient information leaflets.

Conclusion: Diabetic patients are at an increased risk for developing foot infections. Clinical pharmacists can play an active and responsible role in providing education for self-care and medication adherence to the patients.


Keywords

Peripheral Neuropathy, Hyperglycemia, Walking Barefoot, Cephalosporins, Patient Information Leaflets.

Full Text:

 |  (PDF views: 231)

References


  • A.J.M. Boulton. An integrated health care approach is needed: the global burden of diabetic foot disease. Diabetic microvascular complications today. 2006; 23-25.
  • L. Yazdanpanah, M. Nasiri, S. Adarvishi. Literature review on the management of diabetic foot ulcer. World Journal Diabetes. 2015; 6(1), 37-53.
  • International diabetes federation: Diabetes: facts and figures. www.idf.org/about-diabetes/facts-figures. Date accessed: 19/07/2016.
  • S. Tiwari, D.D. Pratyush, A. Dwivedi, S.K. Gupta, M. Rai, S.K. Singh. Microbiological and clinical characteristics of diabetic foot infections in northern India. Journal of Infections in Developing Countries. 2012; 6(4), 329-332.
  • S.O. Oyibo, E.B. Jude, Voyatzoglou, A.J.M. Boulton. Clinical characteristic of patients with diabetic foot problems: changing patterns of foot ulcer presentation. Practical Diabetes International. 2002; 19(1), 10-12.
  • M.S. Bortoletto, S.M. De Andrade, T. Matsuo, C. Haddad Mdo, A.D. González, A.M. Silva. Risk factors for foot ulcers-a cross sectional survey from a primary care setting in Brazil. Primary Care Diabetes.2014; 8(1), 71-76.
  • R. Waaijman, M. De Haart, M.L. Arts, D. Wever, A.J.W.E. Verlouw, F. Nollet, S.A. Bus. Risk factors for plantar foot ulcer recurrence in neuropathic diabetic patients. Diabetes Care. 2014; 37(6), 1697-1705.
  • L.N. McEwen, K.R Ylitalo, J.S. Wrobel, W.H. Herman. Prevalence and risk factors for diabetes-related foot complications in translating research into action for diabetes (TRIAD). Journal of Diabetes Complications. 2013; 27(6), 588-592.
  • G.M. Bengalorkar, K.T. Nagendra. Diabetic foot infections-A review. International Journal of Biological Medical Research. 2011; 2(1), 453-460.
  • I.A. Hunt. Foot infections in diabetes are rarely due to a single microorganism. Diabetic Medicine. 1992; 9(8), 749-752.
  • N. Rao. Anti-infective therapy for foot ulcers in patients with diabetes. Clinical Orthopaedics Related Research. 2005; 439, 87-90.
  • R.G. Frykberg, T. Zgonis, D.G. Armstrong, J. Giurini, A. Edwards, M. Kravette, S. Kravitz, C. Ross, J. Stavosky, R. Stuck, J. Vanore. Diabetic foot disorders: A clinical practice guideline American college of foot and ankle surgeons. Journal of Foot and Ankle Surgery. 2000; 39(5), S1-S60.
  • N.C. Schaper, J.J.V. Netten, J. Apelqvist, B.A. Lipsky, K. Bakker. Prevention and management of foot problems in diabetes: A summary guidance for daily practice 2015,based on the IWGDF guidance documents. Diabetes Metabolism Research and Reviews. 2016; 32(1), 7-15.
  • S. Islam, P. Harnarayan, S. O. Cawich, V. Bheem, V. Mahabir, S. Ramsewak, I. Aziz, V. Naraynsingh. Epidemiology of diabetic foot infections in an eastern Caribbean population: A prospective study. The Permanente Journal. 2013; 17(2), 37-40.
  • M.P. Fransen, E.J. Beune, A.M. Baim-Lance, R.C. Bruessing, M.L. Essink-Bot. Diabetes self-management support for patients with low health literacy: perceptions of patients and providers. Journal of Diabetes. 2015; 7(3), 418-425.
  • S.O. Cawich, S. Islam, S. Hariharan, P. Harnarayan, S. Budhooram, S. Ramsewak, V. Naraynsingh. The economic impact of hospitalization for diabetic foot infections in a Caribbean nation. The Permanente Journal. 2014; 18(1), 101-104.
  • B.A. Lipsky. Diabetic foot infection: current treatment and delaying the “post –antibiotic era”. Diabetes Metababolism Research Reviews. 2016; 32(1), 246-253.
  • S.A. Bus, J.J.V. Netten, L.A. Lavery, M. Monteiro-Soares, A. Rasmussen, Y. Jubiz, P.E. Price. IWGDF guidance on the prevention of foot ulcers in at-risk patients with diabetes. Diabetes Metabolism Research Reviews. 2016; 32(1), 16-24.

Refbacks

  • There are currently no refbacks.